| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/19/2012 | US20120015964 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/19/2012 | US20120015960 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 01/19/2012 | US20120015923 Use of andrographolide compounds for treating inflammation and airway disorders |
| 01/19/2012 | US20120015899 Modified plant virus particles and uses therefor |
| 01/19/2012 | US20120015888 T cell receptors and related materials and methods of use |
| 01/19/2012 | US20120015877 Use of gdf traps to increase red blood cell levels |
| 01/19/2012 | US20120015865 Novel class of cationic lipids for transporting active agents into cells |
| 01/19/2012 | US20120015841 Novel cell lines and methods |
| 01/19/2012 | US20120015840 Methods for generation of rna and (poly)peptide libraries and their use |
| 01/19/2012 | US20120015440 Spheroid composite, spheroid-containing hydrogel and processes for production of same |
| 01/19/2012 | US20120015439 Method for the reconstruction of a tissue-engineered human corneal endothelium |
| 01/19/2012 | US20120015438 Mammallian cell culture process for protein production |
| 01/19/2012 | US20120015437 Long-acting polypeptides and methods of producing same |
| 01/19/2012 | US20120015436 Degraded tpo agonist antibody |
| 01/19/2012 | US20120015435 Pcsk9 antagonists |
| 01/19/2012 | US20120015434 Expansion of nk cells and therapeutic uses thereof |
| 01/19/2012 | US20120015433 Interleukin-1 Alpha Antibodies and Methods of Use |
| 01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
| 01/19/2012 | US20120015425 Cellular Permissivity Factor for Viruses and Uses Thereof |
| 01/19/2012 | US20120015408 Beta-glucosidase variant enzymes and related polynucleotides |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015401 Plasmodium falciparum antigens and methods of use |
| 01/19/2012 | US20120015399 Fluorescent solvatochromic pigment |
| 01/19/2012 | US20120015395 Human Blood-Brain Barrier Endothelial Cells Derived From Pluripotent Stem Cells and Blood-Brain Barrier Model Thereof |
| 01/19/2012 | US20120015384 Interleukin-1 Alpha Antibodies and Methods of Use |
| 01/19/2012 | US20120015380 Anti-polyethylene glycol antibody expressing cell quantify any free polyethylene glycol and polyethylene glycol-derivatized molecules |
| 01/19/2012 | US20120015352 Method of determining sensitivity of human or non-human animal cells to an iap antagonist |
| 01/19/2012 | US20120015343 Methods for increasing isolation yields of cellular products |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120015040 Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014996 Method of diagnosing bladder cancer |
| 01/19/2012 | US20120014992 N-Linked Glycosylation Alteration in E1 Glycoprotein of Classical Swine Fever Virus And Novel Classical Swine Fever Virus Vaccine |
| 01/19/2012 | US20120014983 recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014971 Interleukin-1 Alpha Antibodies and Methods of Use |
| 01/19/2012 | US20120014969 ErbB3 ANTIBODIES |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014962 Method of inhibiting fibrogenesis and treating fibrotic disease |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014959 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |
| 01/19/2012 | US20120014933 Method for Producing Platelets |
| 01/19/2012 | US20120014931 Human late stage motor neuron progenitor cells |
| 01/19/2012 | US20120014926 Activation of Precursor Cells for Cell Therapy |
| 01/19/2012 | US20120014924 Compositions and Methods for Improving the Functional Efficacy of Stem Cell-Derived Cardiomyocytes |
| 01/19/2012 | US20120014911 Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | US20120014876 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/19/2012 | US20120014875 Nucleic acid aptamers |
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | CA2805717A1 Methods for increasing isolation yields of cellular products |
| 01/19/2012 | CA2804750A1 Methods of generating natural killer cells |
| 01/19/2012 | CA2804639A1 Pancreatic islet separation method, and protective solution for protecting pancreatic islet tissue |
| 01/18/2012 | EP2407538A1 Reporter vector for use in evaluation of CYP1A2 |
| 01/18/2012 | EP2407488A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 01/18/2012 | EP2407479A1 Self-assembling peptide and peptide gel with high strength |
| 01/18/2012 | EP2406371A1 Cells useful for immuno-based botulinum toxin serotype a activity assays |
| 01/18/2012 | EP2406369A1 Method for monitoring cell culture |
| 01/18/2012 | EP2406287A1 Antibodies binding to pivka-ii amino acids 13-27 |
| 01/18/2012 | EP2406285A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 01/18/2012 | EP2405929A1 Treatment methods for autoimmune disorders |
| 01/18/2012 | EP2405925A2 Use of serine protease inhibitors in the treatment of neutropenia |
| 01/18/2012 | EP2405742A2 Bioburden-reducing antibiotic composition and method of use |
| 01/18/2012 | EP1950294B1 Novel cell penetrating peptide |
| 01/18/2012 | EP1881062B1 Methode for culturing mesenchymal stem cell and method for producing biological tissue prosthesis |
| 01/18/2012 | EP1851305B1 Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
| 01/18/2012 | EP1836298B1 COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1696945B1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/18/2012 | EP1659858B1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/18/2012 | EP1546327B1 Selection and isolation of living cells using rna-binding probes |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1456366B1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 01/18/2012 | EP1446489B1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 01/18/2012 | EP1430114B1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 01/18/2012 | EP1423508B1 Protein phosphatase stress-related polypeptides and methods of use in plants |
| 01/18/2012 | EP1390075B1 Chemotherapeutic induction of egr-1 promoter activity in gene therapy |
| 01/18/2012 | EP1257822B1 Her-2 binding antagonists |
| 01/18/2012 | EP1123388B1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 01/18/2012 | EP1053256B9 Antibodies to death receptor 4 (dr4) and uses thereof |
| 01/18/2012 | CN1813642B Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 01/18/2012 | CN102325878A Target populations of oligodendrocyte precursor cells and methods of making and using same |
| 01/18/2012 | CN102325877A Compositions for treating allergic or asthmatic condition |
| 01/18/2012 | CN102325876A Brewing method |
| 01/18/2012 | CN102321732A High-throughput screening method for porcine calcium-sensing receptor (CAR) agonist |
| 01/18/2012 | CN102321720A Method for producing pure human-derived monoclonal antibody by mixed cell culture |
| 01/18/2012 | CN102321668A Method for expressing recombinant human coagulation factor VII and special vector thereof |
| 01/18/2012 | CN102321661A Eukaryotic expression recombinant plasmid and construction method thereof and Vero cell line stably expressing the plasmid |
| 01/18/2012 | CN102321658A Mutation method of recombinant protein of pig somatic cells |
| 01/18/2012 | CN102321655A Pseudo-attP site based integrated general-purpose expression vector and construction method and application thereof |
| 01/18/2012 | CN102321649A Lycium chinense miller lycopene beta-cyclase gene, recombinant vector containing gene, host cell and application |
| 01/18/2012 | CN102321639A Preparation method of virus-like particles (VLPs) of Chikungunya virus (CHIKV) and its application |
| 01/18/2012 | CN102321637A Chinese fowlpox virus 282E4 low virulent strain complete genome sequence and application thereof |
| 01/18/2012 | CN102321632A Chloroplast transit peptides for efficient targeting of DMO and uses thereof |
| 01/18/2012 | CN102321627A Preparation method of human-infected TRIM25 gene foot and mouth disease virus inhibiting cell line and application thereof |